Related Experiment Video
Updated: Aug 9, 2025
09:19
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
9.1K
Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives
María Marcos-Jubilar1, Ramón Lecumberri1,2, José A Páramo1,3
1Hematology and Hemotherapy Service, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Journal of Clinical Medicine
|February 25, 2023
Summary
Thromboinflammation links blood clotting and inflammation in conditions like sepsis and COVID-19. This review explores immunothrombosis mechanisms to develop therapies that reduce clotting risk by managing inflammation.
Area of Science:
- Immunology
- Hematology
- Pathophysiology
Background:
- Thromboinflammation, or immunothrombosis, describes the interplay between coagulation and inflammation.
- This phenomenon is implicated in various diseases, including sepsis, venous thromboembolism, and COVID-19 associated coagulopathy.
Purpose of the Study:
- To review current data on the mechanisms underlying immunothrombosis.
- To explore novel therapeutic strategies targeting inflammation to mitigate thrombotic risk.
Main Methods:
- Literature review of existing research on immunothrombosis.
- Analysis of studies investigating the link between inflammation and coagulation pathways.
Main Results:
- Detailed overview of the molecular and cellular mechanisms driving immunothrombosis.
- Identification of key inflammatory mediators contributing to thrombotic events.
Conclusions:
- Understanding immunothrombosis mechanisms is crucial for developing effective treatments.
- Targeting inflammation presents a promising therapeutic avenue for reducing thrombotic risk in associated conditions.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
804
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
804
01:29Venous Thrombosis III: Interprofessional Care
15
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
15
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
22
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
22
01:29Microorganisms in Medicine and Therapeutics
103
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
103
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.6K